REPOS PHARMA ApS: Financial statements 2016
CVR: 35841555
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
REPOS PHARMA ApS (CVR 35841555) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK -63,417 compared with DKK -264,799 the year before. Equity in the 2016 report amounted to DKK 1,805. The solvency ratio was 7.4%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -63,417
- Equity
- DKK 1,805
- Total Assets
- DKK 24,305
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 0 | -63 t. | 2 t. | - |
| 2015 | - | -298 t. | -265 t. | 65 t. | - |
Official annual report
Find more companies like REPOS PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
REPOS PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -298,039, and the net result was DKK -264,799.
As of April 19, 2016, Torsten Bjørn is registered as director of REPOS PHARMA ApS.
As of April 19, 2016, Henrik Lasse Lindblad has stepped down as adm. dir of REPOS PHARMA ApS.
About REPOS PHARMA ApS
REPOS PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2014. The company has been dissolved on 26 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK -63,417 compared with DKK -264,799 the year before. Equity in the 2016 report amounted to DKK 1,805.